Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.18%
#3 CoW Protocol CoW Protocol +41.66%
#4 Glidr Glidr +36.87%
#5 Humanity Humanity +25.34%
#6 Walrus Walrus +23.68%
#7 Codatta Codatta +19.58%
#8 Enso Enso +18.19%
#9 The Black Bull The Black Bull +15.04%
#10 Collector Crypt Collector Crypt +14.18%
Coin of the day
EXOD EXOD
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
Hisse Senetlerindeki Sıralama #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
Hisse Fiyatı
$0.6
Son senkronizasyon: 2024-08-14
Piyasa Değeri
$2.09M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
0.00%
Ülke
SG
Ticaret ASLAN Pharmaceuticals Limited (ASLN)

Kategori

Healthcare
ASLAN Pharmaceuticals Limited (ASLN) için P/B oranı
August 2026 itibarıyla P/B oranı TTM: -0.19
ASLAN Pharmaceuticals Limited şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/B oranı (TTM) -0.19'dir. 2022 yılının sonunda şirketin P/B oranı 0.96 idi.
ASLAN Pharmaceuticals Limited için P/B oranı geçmişi 2014 - 2026 arası
Her yılın sonunda P/B oranı
Yıl P/B Oranı Değiştir
2026 (TTM) -0.19 -11.57%
2023 -0.21 -121.55%
2022 0.96 135.76%
2021 0.41 -118.92%
2020 -2.15 -82.88%
2019 -12.58 -1,216.28%
2018 1.13 -10.51%
2017 1.26 11.69%
2016 1.13 -308.68%
2015 -0.54 496.91%
2014 -0.09 0.00%
Benzer şirketler veya rakipler için P/B oranı
Şirket P/B Oranı P/B Oranı Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -3,515.13%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -3,460.96%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -1,963.87%
BE